Benedict Financial Advisors Inc Abbott Laboratories Transaction History

Benedict Financial Advisors Inc

$421 Million
Q3 2024

A detailed history of Benedict Financial Advisors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Benedict Financial Advisors Inc holds 33,636 shares of ABT stock, worth $3.9 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

33,636

Previous 34,084 1.31%

Holding current value

$3.9 Million

Previous $3.54 Million 8.27%

% of portfolio

0.91%

Previous 0.9%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $44,831 - $52,922	-448 Reduced 1.31%	33,636 $3.83 Million
Q2 2024 Jul 30, 2024	SELL	$100.73 - $112.44 $15,109 - $16,866	-150 Reduced 0.44%	34,084 $3.54 Million
Q1 2024 Apr 25, 2024	SELL	$109.52 - $120.96 $31,760 - $35,078	-290 Reduced 0.84%	34,234 $3.89 Million
Q4 2023 Jan 29, 2024	SELL	$90.19 - $110.4 $42,750 - $52,329	-474 Reduced 1.35%	34,524 $3.8 Million
Q3 2023 Oct 18, 2023	SELL	$95.53 - $114.62 $3,630 - $4,355	-38 Reduced 0.11%	34,998 $3.39 Million
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $16,326 - $18,190	-162 Reduced 0.46%	35,036 $3.82 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $90,564 - $106,599	-935 Reduced 2.59%	35,198 $3.56 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $12,167 - $14,274	-128 Reduced 0.35%	36,133 $3.97 Million
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $30,769 - $35,625	-318 Reduced 0.87%	36,261 $3.51 Million
Q2 2022 Jul 28, 2022	BUY	$102.07 - $123.37 $18,780 - $22,700	184 Added 0.51%	36,579 $3.97 Million
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $40,819 - $49,776	-358 Reduced 0.97%	36,395 $4.31 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $86,531 - $105,953	-749 Reduced 2.0%	36,753 $5.17 Million
Q3 2021 Oct 29, 2021	SELL	$116.66 - $129.06 $47,363 - $52,398	-406 Reduced 1.07%	37,502 $4.43 Million
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $58,396 - $68,740	-552 Reduced 1.44%	37,908 $4.4 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $134,852 - $158,876	-1,239 Reduced 3.12%	38,460 $4.61 Million
Q4 2020 Feb 02, 2021	SELL	$105.0 - $114.42 $57,120 - $62,244	-544 Reduced 1.35%	39,699 $4.35 Million
Q3 2020 Nov 03, 2020	SELL	$91.64 - $111.29 $191,252 - $232,262	-2,087 Reduced 4.93%	40,243 $4.38 Million
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $17,917 - $22,932	-234 Reduced 0.55%	42,330 $3.87 Million
Q1 2020 Apr 21, 2020	SELL	$62.82 - $91.86 $48,371 - $70,732	-770 Reduced 1.78%	42,564 $3.36 Million
Q4 2019 Feb 04, 2020	SELL	$78.51 - $87.4 $26,457 - $29,453	-337 Reduced 0.77%	43,334 $3.76 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $133,890 - $145,178	-1,636 Reduced 3.61%	43,671 $3.65 Million
Q2 2019 Aug 01, 2019	SELL	$72.88 - $85.0 $99,189 - $115,685	-1,361 Reduced 2.92%	45,307 $3.81 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $144,359 - $174,530	-2,180 Reduced 4.46%	46,668 $3.73 Million
Q4 2018 Jan 30, 2019	SELL	$65.56 - $74.27 $166,260 - $188,348	-2,536 Reduced 4.94%	48,848 $3.53 Million
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $106,964 - $129,040	-1,759 Reduced 3.31%	51,384 $3.77 Million
Q2 2018 Jul 24, 2018	SELL	$57.57 - $63.54 $44,616 - $49,243	-775 Reduced 1.44%	53,143 $3.24 Million
Q1 2018 May 02, 2018	SELL	$56.27 - $63.62 $147,539 - $166,811	-2,622 Reduced 4.64%	53,918 $3.23 Million
Q4 2017 Feb 05, 2018	SELL	$53.68 - $57.47 $140,158 - $150,054	-2,611 Reduced 4.41%	56,540 $3.23 Million
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $2.84 Million - $3.17 Million	59,151	59,151 $3.16 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benedict Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benedict Financial Advisors Inc with notifications on news.

Account

Benedict Financial Advisors Inc Abbott Laboratories Transaction History